GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (FRA:QDI) » Definitions » EV-to-EBIT

Quest Diagnostics (FRA:QDI) EV-to-EBIT : 15.91 (As of Apr. 30, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Quest Diagnostics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Quest Diagnostics's Enterprise Value is €19,031 Mil. Quest Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €1,196 Mil. Therefore, Quest Diagnostics's EV-to-EBIT for today is 15.91.

The historical rank and industry rank for Quest Diagnostics's EV-to-EBIT or its related term are showing as below:

FRA:QDI' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.79   Med: 13.74   Max: 18.84
Current: 15.75

During the past 13 years, the highest EV-to-EBIT of Quest Diagnostics was 18.84. The lowest was 6.79. And the median was 13.74.

FRA:QDI's EV-to-EBIT is ranked better than
63.3% of 109 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.54 vs FRA:QDI: 15.75

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Quest Diagnostics's Enterprise Value for the quarter that ended in Mar. 2024 was €18,007 Mil. Quest Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €1,196 Mil. Quest Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 6.64%.


Quest Diagnostics EV-to-EBIT Historical Data

The historical data trend for Quest Diagnostics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics EV-to-EBIT Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.77 9.58 8.94 15.82 15.69

Quest Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.88 17.20 16.04 15.69 15.28

Competitive Comparison of Quest Diagnostics's EV-to-EBIT

For the Diagnostics & Research subindustry, Quest Diagnostics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's EV-to-EBIT falls into.



Quest Diagnostics EV-to-EBIT Calculation

Quest Diagnostics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19031.097/1196.479
=15.91

Quest Diagnostics's current Enterprise Value is €19,031 Mil.
Quest Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,196 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest Diagnostics  (FRA:QDI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Quest Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=1196.479/18006.99
=6.64 %

Quest Diagnostics's Enterprise Value for the quarter that ended in Mar. 2024 was €18,007 Mil.
Quest Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,196 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest Diagnostics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (FRA:QDI) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (FRA:QDI) Headlines

No Headlines